Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Myelo Therapeutics Takes on Unmet Needs in Cancer

Posted on November 17th, 2017 by in Pharma R&D

Many pharmaceutical and biotechnology start-ups have been founded for the purpose of taking on unmet needs. It has often been difficult for the larger, more established pharma companies to focus on these narrower problems, so the leaner, scrappier start-ups are putting their passion and brainpower to the challenges that have yet to be tackled. (more…)

Disrupting innovation: From geography, penguins and ocean currents to diagnosing disease by its smell

Posted on November 15th, 2017 by in Pharma R&D

banner-1235602_640

How to become aware of what I don’t know? These insights can stimulate disruption. They help us see a whole new world or perhaps a pattern of activities that need to change. As Donald Rumsfeld described, it is those things we don’t know we don’t know that can be issues for the future. They can also be lost opportunities in scientific understanding and commercial success. (more…)

Managing Data and the Digital Revolution with Emerging Technologies

Posted on November 13th, 2017 by in Pharma R&D

The scholarly publishing industry has experienced major shifts in the last few decades. Research journals have long captured the insights of scientific research, further fueling the work of other scientists. (more…)

Considering lifestyle and environment to maximize the economic value of R&D

Posted on November 10th, 2017 by in Pharma R&D

With an interest in systems approaches, I am always on the look-out for interesting papers in this area. A recent paper in Drug Discovery Today caught my eye for several reasons (1). The first was the extent of the problem with non-alcoholic liver disease. (more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 7